Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Chronic Pancreatitis I: Introduction01:25

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
Acute Pancreatitis I: Introduction01:27

Acute Pancreatitis I: Introduction

Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of a predictive model for postoperative body mass index and diabetes outcomes after metabolic bariatric surgery: retrospective cohort study.

BJS open·2026
Same author

Futility in adenosquamous pancreatic cancer.

World journal of surgical oncology·2026
Same author

Sleeve gastrectomy versus Roux-en-Y-gastric bypass in patients with body mass index over 50 kg/m2: international multicentre cohort.

BJS open·2026
Same author

Reversal of Roux-en-Y Gastric Bypass: A Swedish National Cohort Study.

Annals of surgery·2026
Same author

Factors associated with anemia after bariatric surgery.

Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery·2026
Same author

Best achievable benchmarks in bariatric surgery: a nationwide registry study.

Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery·2026

Related Experiment Video

Updated: Jun 12, 2026

An Obstructive Chronic Pancreatitis Model Established Through Electrocoagulation
06:28

An Obstructive Chronic Pancreatitis Model Established Through Electrocoagulation

Published on: October 31, 2025

Chronic pancreatitis: potential future interventions.

Daniel Ansari1, Ellen Andersson, Bodil Andersson

  • 1Department of Surgery, Clinical Sciences Lund, Lund University and Lund University Hospital, Lund, Sweden.

Scandinavian Journal of Gastroenterology
|June 1, 2010
PubMed
Summary
This summary is machine-generated.

Activated pancreatic stellate cells drive fibrosis in chronic pancreatitis, a process poorly understood. This review explores mechanisms for developing new therapies to combat pancreatic fibrosis.

More Related Videos

A Mouse Model for Chronic Pancreatitis via Bile Duct TNBS Infusion
06:44

A Mouse Model for Chronic Pancreatitis via Bile Duct TNBS Infusion

Published on: February 28, 2021

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
07:38

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection

Published on: May 10, 2024

Related Experiment Videos

Last Updated: Jun 12, 2026

An Obstructive Chronic Pancreatitis Model Established Through Electrocoagulation
06:28

An Obstructive Chronic Pancreatitis Model Established Through Electrocoagulation

Published on: October 31, 2025

A Mouse Model for Chronic Pancreatitis via Bile Duct TNBS Infusion
06:44

A Mouse Model for Chronic Pancreatitis via Bile Duct TNBS Infusion

Published on: February 28, 2021

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
07:38

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection

Published on: May 10, 2024

Area of Science:

  • Gastroenterology and Hepatology
  • Cell Biology
  • Pathology

Background:

  • Chronic pancreatitis is a prevalent disorder with incompletely understood pathogenic mechanisms.
  • Activated pancreatic stellate cells are increasingly recognized as key players in fibrosis development in chronic pancreatitis and pancreatic cancer.
  • Quiescent stellate cells transform phenotypically during pancreatic injury, increasing extracellular matrix synthesis.

Purpose of the Study:

  • To review current insights into the pathological mechanisms underlying chronic pancreatitis.
  • To discuss the applicability of these insights for developing future therapeutic approaches.
  • To highlight the role of activated pancreatic stellate cells in fibrosis.

Main Methods:

  • Literature review of recent research on chronic pancreatitis pathogenesis.
  • Analysis of the role of pancreatic stellate cells in fibrosis.
  • Exploration of potential therapeutic targets for pancreatic fibrosis.

Main Results:

  • Activated pancreatic stellate cells are central to the fibrotic process in chronic pancreatitis.
  • Phenotypic transformation of stellate cells involves smooth muscle alpha-actin expression and ECM protein synthesis.
  • Current therapies do not specifically target or reverse pancreatic fibrosis.

Conclusions:

  • Understanding the mechanisms of pancreatic stellate cell activation is crucial for developing novel therapies.
  • Targeting activated pancreatic stellate cells may offer a promising strategy to prevent or reverse pancreatic fibrosis.
  • Further research into the pathological pathways of chronic pancreatitis is needed to inform therapeutic development.